WCM-Rutgers NJMS CTU Supplement for COVID Testing

WCM-Rutgers NJMS CTU 针对新冠病毒检测的补充

• 批准号: 10166397
• 负责人: ROY M. GULICK
• 金额: $ 30万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-06-16 至 2021-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10166397
• 关键词: AIDS clinical trial group; Acquired Immunodeficiency Syndrome; Address; Administrative Supplement; Adult Respiratory Distress Syndrome; Affect; Area; COVID-19; COVID-19 pandemic; Clinical; Clinical Trials; Clinical Trials Network; Clinical Trials Unit; Communities; Community Healthcare; Coronavirus; Enrollment; Ensure; Funding; Future; HIV prevention trials network; Health Personnel; Individual; Infection; Laboratories; Lesbian Gay Bisexual Transgender Queer; Location; Minority; New Jersey; Research Institute; Services; Severe Acute Respiratory Syndrome; Site; Testing; United States; Work; clinical research site; cohort; coronavirus disease; high risk population; infection rate; interest; medical schools; named group; pandemic disease; programs; public health research

ABSTRACT The Rutgers New Jersey Medical School (NJMS) Clinical Research Site (CRS) 31786 is requesting $300,000 in funding to help support Severe Acute Respiratory Distress Syndrome Coronavirus-2 (SARS-CoV-2) testing. The CRS is part of the Weill Cornell-Rutgers NJMS Clinical Trials Unit and has been a site for two Division of AIDS (DAIDS) funded clinical trials networks: AIDS Clinical Trials Group (ACTG) and HIV Prevention Trials Network (HPTN) for fifteen years. The program plans to provide SARS-CoV-2 testing by leveraging its existing relationships with the local community and partnering with the clinical laboratory located at Public Health Research Institute (PHRI), also a Rutgers facility to perform SARS-CoV-2 testing using the Cepheid testing platform. The Cepheid COVID-19 testing platform has been developed at PHRI with Cepheid and is one of the most sensitive tests currently available to detect SARS-Co-V 2 infection. We will provide SARS-CoV-2 testing at the CRS, in an adjacent building and on a mobile van. These testing locations are well-known and easily accessible to the community, healthcare workers and other high-risk groups. We will also attempt to ensure that special populations such as minorities and the LGBTQ community have access to the test. Finally, this will help the CRS further strengthen its relationship with the community and allow the unit to provide an essential service to this hard-hit community. If funded, this project will allow us to rapidly increase the availability of SARS CoV-2 testing and help contribute to the urgent need for additional COVID testing in an underserved community located near the epicenter of the COVID-19 pandemic in the United States.

抽象的 罗格斯新泽西医学院（NJMS）临床研究地点（CRS）31786是 要求$ 300,000的资金来帮助支持严重的急性呼吸窘迫综合症 冠状病毒2（SARS-COV-2）测试。 CRS是Weill Cornell-Rutgers NJM的一部分 临床试验单元，一直是辅助临床试验的两种艾滋病（DAIDS）的地点 网络：艾滋病临床试验组（ACTG）和HIV预防试验网络（HPTN） 十五年。 该计划计划通过利用其现有关系与 当地社区并与位于公共卫生的临床实验室合作 研究所（PHRI），也是罗格（Rutgers）的设施 CepheID测试平台。 Cepheid Covid-19测试平台已在PHRI开发 使用Cepheid，是目前可用于检测SARS-CO-V 2的最敏感测试之一 感染。 我们将在CRS，相邻建筑物和移动面包车上提供SARS-COV-2测试。 这些测试地点是众所周知的，社区很容易获得医疗保健 工人和其他高风险群体。我们还将尝试确保特殊人群这样 由于少数民族和LGBTQ社区可以访问测试。最后，这将帮助CRS 进一步加强与社区的关系，并允许该单位提供必不可少的 为这个艰苦的社区提供服务。 如果资助，该项目将使我们能够迅速增加SARS COV-2测试的可用性和 有助于迫切需要在服务不足的社区中进行其他共同测试 位于美国共同 - 19日大流行的中心附近。